⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NITO News
N2OFF, Inc. Common Stock
N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination
globenewswire.com
NITO
N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers
globenewswire.com
NITO
N2OFF Announces Closing of Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
globenewswire.com
NITO
N2OFF Regains Compliance with Nasdaq Minimum Bid Price Requirement
globenewswire.com
NITO
N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
globenewswire.com
NITO